Patent ID: 7759060

Claim:
A method for determining if prostate cells are cancerous, the method consisting of: a) obtaining said prostate cells; b) determining an expression of polynucleotides encoding Hepsin (transmembrane protease serine 1) genes in said prostate cells relative to normal prostate cells; c) determining an expression of polynucleotides encoding X-box binding protein 1 genes in said prostate cells relative to normal prostate cells; d) determining an expression of polynucleotides encoding Folate hydrolase (Prostate specific membrane antigen) 1 genes in said prostate cells relative to normal prostate cells; e) determining an expression of polynucleotides encoding Glutathione S-transferase M4 genes in said prostate cells relative to normal prostate cells; f) determining an expression of polynucleotides encoding Intersectin 1 (SH3 domain protein) genes in said prostate cells relative to normal prostate cells; g) determining an expression of polynucleotides encoding Nel-like 2 genes in said prostate cells relative to normal prostate cells; h) determining an expression of polynucleotides encoding D component of complement (adipsin) genes in said prostate cells relative to normal prostate cells; i) determining an expression of polynucleotides encoding Latent transforming growth factor beta binding protein 4 genes in said prostate cells relative to normal prostate cells; j) determining that said prostate cells are cancerous in the event that said polynucleotides encoding Hepsin (transmembrane protease serine 1); X-box binding protein 1; and Folate hydrolase (Prostate specific membrane antigen) 1; genes are overexpressed in said prostate cells relative to normal prostate cells and in the event that said polynucleotides encoding Glutathione S-transferase M4; Intersectin 1 (SH3 domain protein); Nel-like 2; D component of complement (adipsin); and Latent transforming growth factor beta binding protein 4; genes are underexpressed in said prostate cells relative to normal prostate cells.